Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bioactive lipids in inflammatory bowel diseases – From pathophysiological alterations to therapeutic opportunities
Mireille Alhouayek, Hafsa Ameraoui, Giulio G. Muccioli
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2020) Vol. 1866, Iss. 2, pp. 158854-158854
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Attenuation of 7-ketocholesterol- and 7β-hydroxycholesterol-induced oxiapoptophagy by nutrients, synthetic molecules and oils: Potential for the prevention of age-related diseases
Thomas Nury, Aline Yammine, Imen Ghzaiel, et al.
Ageing Research Reviews (2021) Vol. 68, pp. 101324-101324
Closed Access | Times Cited: 61
Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases
Lidiya V. Boldyreva, Maryana V. Morozova, Snezhanna S. Saydakova, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11682-11682
Open Access | Times Cited: 47
Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome
Stuart M. Brierley, Beverley Greenwood‐Van Meerveld, Giovanni Sarnelli, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 1, pp. 5-25
Closed Access | Times Cited: 26
Serum Lipidomic Screen Identifies Key Metabolites, Pathways, and Disease Classifiers in Crohn’s Disease
Romain Clément, Gabrielle Boucher, Anik Forest, et al.
Inflammatory Bowel Diseases (2023) Vol. 29, Iss. 7, pp. 1024-1037
Closed Access | Times Cited: 14
The role of sphingosine-1-phosphate in the gut mucosal microenvironment and inflammatory bowel diseases
Fei Zou, Su Wang, Mengmeng Xu, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 11
Anti-inflammatory celastrol promotes a switch from leukotriene biosynthesis to formation of specialized pro-resolving lipid mediators
Simona Pace, Kehong Zhang, Paul M. Jordan, et al.
Pharmacological Research (2021) Vol. 167, pp. 105556-105556
Closed Access | Times Cited: 25
Mucosal and Plasma Metabolomes in New-onset Paediatric Inflammatory Bowel Disease: Correlations with Disease Characteristics and Plasma Inflammation Protein Markers
Niklas Nyström, Stefanie Prast‐Nielsen, Mário S. P. Correia, et al.
Journal of Crohn s and Colitis (2022) Vol. 17, Iss. 3, pp. 418-432
Open Access | Times Cited: 16
Emerging roles of host and microbial bioactive lipids in inflammatory bowel diseases
Hisako Kayama, Kiyoshi Takeda
European Journal of Immunology (2023) Vol. 53, Iss. 8
Open Access | Times Cited: 10
Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin
Gian Mario Cortes, Maria Antonietta Marcialis, Flaminia Bardanzellu, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 14
The Fatty Acid-Based Erythrocyte Membrane Lipidome in Dogs with Chronic Enteropathy
Paolo Emidio Crisi, A Luciani, Morena Di Tommaso, et al.
Animals (2021) Vol. 11, Iss. 9, pp. 2604-2604
Open Access | Times Cited: 14
Zeaxanthin Dipalmitate-Enriched Emulsion Stabilized with Whey Protein Isolate-Gum Arabic Maillard Conjugate Improves Gut Microbiota and Inflammation of Colitis Mice
Xuhui Kan, Wangting Zhou, Weiqi Xu, et al.
Foods (2022) Vol. 11, Iss. 22, pp. 3670-3670
Open Access | Times Cited: 9
Effect of Different Dietary Regimes on the Gut Microbiota and Fecal Metabolites of Père David’s Deer
Junai Zhen, Yijun Ren, Huidan Zhang, et al.
Animals (2022) Vol. 12, Iss. 5, pp. 584-584
Open Access | Times Cited: 8
Paenibacillus exopolysaccharide repairs GI inflammation by suppressing MAPK and NF-κB and restoring lipid production in Caco-2 cell line
Jing Zhang, LI Zhi-qiang, Ru-Jing Zheng, et al.
Journal of Functional Foods (2023) Vol. 107, pp. 105709-105709
Open Access | Times Cited: 4
Sex hormone deprivation abolishes sex‐specific differences in murine colon inflammation and related lipid mediator production
Simona Pace, Katharina P. L. Meyer, Fabiana Troisi, et al.
The FASEB Journal (2024) Vol. 38, Iss. 14
Open Access | Times Cited: 1
Unique sterol metabolite shifts in inflammatory bowel disease and primary sclerosing cholangitis
Silke Matysik, Tanja Elger, Muriel Huss, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2024) Vol. 245, pp. 106621-106621
Open Access | Times Cited: 1
Fecal Nervonic Acid as a Biomarker for Diagnosing and Monitoring Inflammatory Bowel Disease
C Kunst, Tanja Elger, Johanna Loibl, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2764-2764
Open Access | Times Cited: 1
Bioactive lipids and their metabolism: New therapeutic opportunities for Parkinson's disease
Wenjing Shen, Li Jiang, Jingyi Zhao, et al.
European Journal of Neuroscience (2021) Vol. 55, Iss. 3, pp. 846-872
Closed Access | Times Cited: 10
Sishen Pill Ameliorates Dextran Sulfate Sodium (DSS)-Induced Colitis with Spleen-Kidney Yang Deficiency Syndromes: Role of Gut Microbiota, Fecal Metabolites, Inflammatory Dendritic Cells, and TLR4/NF-κB Pathway
Wei Ge, Bu-Gao Zhou, Youbao Zhong, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 6
N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice
Pauline Bottemanne, Owein Guillemot‐Legris, Adrien Paquot, et al.
Neurotherapeutics (2021) Vol. 18, Iss. 3, pp. 1815-1833
Open Access | Times Cited: 8
Association between the use of lipid‐lowering drugs and the risk of inflammatory bowel disease
Xuxu Liu, Zhenyi Lv, Zhihong Xie, et al.
European Journal of Clinical Investigation (2023) Vol. 53, Iss. 12
Closed Access | Times Cited: 3
Emerging mechanisms by which endocannabinoids and their derivatives modulate bacterial populations within the gut microbiome
Melissa Ellermann
Advances in Drug and Alcohol Research (2023) Vol. 3
Open Access | Times Cited: 3
Untargeted metabolomics identifies potential serum biomarkers associated with Crohn’s disease
Bo Chen, Yongjun Wang, Qing Wang, et al.
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 5, pp. 1751-1761
Closed Access | Times Cited: 3
Genotype-based “virtual” metabolomics in a clinical biobank identifies novel metabolite-disease associations
Minoo Bagheri, Andrei Bombin, Mingjian Shi, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Evaluation of the fatty acid-based erythrocyte membrane lipidome in cats with food responsive enteropathy, inflammatory bowel disease and low-grade intestinal T-cell lymphoma
Paolo Emidio Crisi, Maria Veronica Giordano, A Luciani, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0307757-e0307757
Open Access
The role of anandamide in digestive and defensive functions of the gut
Keith A. Sharkey, Derek K.L. Tsang
Elsevier eBooks (2024), pp. 445-473
Closed Access
Page 1 - Next Page

Scroll to top